The DOJ has focused particularly on the payment of kickbacks that induce physicians to prescribe more, or more expensive, opioids.
Last week, President Trump unveiled the administration’s new plan to combat the opioid epidemic. In 2016, more than 11 million Americans misused prescription opioids, resulting in 42,000 related deaths and $504 billion in related economic costs. The plan includes stiffer penalties for high-volume drug dealers, including seeking the death penalty where it is appropriate under current law, and a stated goal to reduce prescriptions of the powerful painkillers by one-third nationwide.
Long before this week’s announcement, however, the U.S. Department of Justice (DOJ) has been hard at work on these goals. Last summer, as we reported on Monitor Monday, Attorney General Jeff Sessions announced opioid-related healthcare fraud as a priority for the agency. In 2017, 34 percent of defendants charged by the Medicare Fraud Strike Force were charged with crimes involving opioid prescriptions.
The DOJ has focused particularly on the payment of kickbacks that induce physicians to prescribe more, or more expensive, opioids. This in violation of a law known as “the anti-kickback statute,” which prohibits medical providers from paying or receiving kickbacks, remuneration, or anything of value in exchange for referrals of patients who will receive treatment paid for by government healthcare programs, such as Medicare and Medicaid. The law is designed to keep medical treatment decisions free from the influence of potential monetary gain. As the DOJ has explained, “[p]atients are entitled to be sure that the care they receive is based on their actual medical needs rather than the financial interests of their physicians.” Violations of the anti-kickback law can also be violations of the False Claims Act, which allows private citizens to blow the whistle on fraud against the government, and share in the amount recovered.
Last October, Dr. John Kapoor, the chief executive officer of Insys Therapeutics, a manufacturer of fentanyl (a powerful opioid), was charged with violations of the False Claims Act. Prosecutors alleged the company paid hundreds of thousands of dollars to doctors in exchange for prescribing a spray called Subsys that contained fentanyl; Subsys is 100 times stronger than morphine. The scheme was brought to light by a whistleblower who was a former Insys employee. Dr. Kapoor pleaded not guilty in November, and the case is ongoing.
Two weeks ago, one of the doctors who received payments from Insys was sentenced to 51 months in prison by a federal court in Rhode Island. Dr. Jerrold Rosenberg, whose sentencing hearing included testimony from three former patients about the debilitating effects they experienced from the drug, received over $180,000 in payments from the company. His son was also a sales representative for Insys. In addition to jail time, Dr. Rosenberg will also have to pay Medicare over $750,000 in restitution due to his overprescribing of the spray.
Just last Friday, prosecutors in New York charged five more doctors with accepting kickbacks from Insys. All five allegedly received lavish payments from the company that were disguised as speaking fees, and totaled hundreds of thousands of dollars. Each one of the doctors charged also prescribed over $500,000 of Subsys in a single quarter.
With many related actions involving the kickback scheme currently ongoing, this will be a case to watch.
Given the vast quantity of information published by the federal government, Medicare Administrative Contractors (MACs), consultants, and others, it can be easy to lose track
The first piece of news for today is that the Centers for Medicare & Medicaid Services (CMS) has finally released a new version of the
Please log in to your account to comment on this article.
Uncover essential coding insights with nationally recognized coding authority Kay Piper, RHIA, CDIP, CCS. Through ICD10monitor’s interactive, on‑demand webcast series, Kay walks you through the AHA’s 2026 ICD‑10‑CM/PCS Quarterly Coding Clinics, translating each update into practical, easy‑to‑apply guidance designed to sharpen precision, ensure compliance, and strengthen day‑to‑day decision‑making. Available shortly after each official release.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s fourth quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s third quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s second quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
